🙌 The 3rd edition of the ‘Amyloidosis Symposium’, chaired by Prof. Antoine Bondue, Prof. Jan De Bleecker, Prof. Michel Delforge & Prof. Anne-Catherine Pouleur, took place in Grimbergen last month.
🗒️ This exciting amyloidosissymposium emphasized the importance of multidisciplinary collaboration between different clinicians.
Prof. Marianna Fontana, Prof. Violaine Planté-Bordeneuve & Prof. Nathalie Meuleman focused on recent advances in the identification and treatment of ATTR and AL amyloidosis. Dr. Philippe Debonnaire & Prof. Monique Minnema discussed in depth the importance of real data concerning patients with amyloidosis (AL and ATTR).
🎬 Click on this link to enjoy the atmosphere of this edition: https://lnkd.in/e2ptuiSq
🙏 to our industry partners Alnylam Pharmaceuticals, The Janssen Pharmaceutical Companies of Johnson & Johnson, Pfizer, The Binding Site, AstraZeneca & BridgeBio for their valuable support.